The copper T380A intrauterine device in women with type II diabetes mellitus

Obstet Gynecol. 1994 Dec;84(6):1006-9.


Objective: To evaluate the safety and efficacy of the copper T380A intrauterine device (IUD) in women with type II, non-insulin-dependent diabetes mellitus.

Methods: From June 1988, 176 women with type II diabetes, in whom the copper T380A IUD was inserted, were followed prospectively until: study closure (June 1993); termination for pregnancy, expulsion, or removal for medical or personal reasons; or termination for loss to follow-up.

Results: Sixteen women never returned after initial insertion, leaving 160 women who were followed a total of 3066 months, with 117 continuing follow-up after their reexamination visit 6-12 weeks after insertion. None developed acute salpingitis. The overall removal rates per 100 woman-years were as follows: for pregnancy, 1.57; for expulsion, 1.96; for discontinuation because of medical reasons (including pain and bleeding), 4.31; and for personal reasons, 3.91. The continuation rate at the end of 3 years after insertion was 70%.

Conclusion: The copper T380A IUD appears to be safe and effective in women with type II diabetes when standard criteria for IUD insertion are followed.

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 2*
  • Female
  • Follow-Up Studies
  • Humans
  • Intrauterine Device Expulsion
  • Intrauterine Devices, Copper* / adverse effects
  • Pregnancy
  • Prospective Studies